Overview
Our Whippany, NJ, USA facility provides comprehensive cGMP drug product manufacturing and laboratory services. The facility has an excellent compliance record with resulting regulatory approvals (FDA, MHRA, ANVISA, and US DEA). With a broad range of capabilities and technologies, our site has the resources required by our clients to ensure successful program execution.
Whippany is perfectly suited to handle a wide variety of batch sizes. The site operates small-scale through commercial-scale equipment ensuring that clients’ development, clinical, registration, and commercial needs can be met by a single facility. Manufacturing unit operations such as high-shear and top-spray granulation, roller compaction, compression, encapsulation, and film coating are available at differing scales. Liquid solution and suspension manufacturing and sterile ointment manufacturing services are also available. Finished goods packaging for all manufactured dosage forms is performed on-site. Our on-site analytical development laboratories support method development, method transfers, cleaning methods, and method validations. Additionally, our commercial laboratories perform raw material testing, QC release, stability, and micro testing services.
Facility Details
Our Whippany site is fully equipped to support the following dosage forms:
- Oral dosage forms, including tablets (mono and bi-layer), capsules, powders, mini tablets and beads, powders, and granules for reconstitution
- Liquids, including solutions and suspensions
- Semi-solids (ointments)
- Suppositories
- Controlled drugs
- Handling of potent compounds up to OEB 3 (OEL ≥1.0 & <10 μg/m3)
- Controlled/sustained release dosage forms
- Pediatric dosage forms